1
Plaque Assessment
Enter per-vessel data — totals auto-calculate
* Low attenuation plaque is a subset of non-calcified plaque and is not added separately to the total.
Calcified
—
Non-Calcified
—
Low Atten.
—
Total Plaque
—
mm³
2
Base Risk Stage
3
Percentile & Risk Enhancers
4
Final Stage
Enter plaque volumes above.
5
Medical Management
Determined by final stage.
Note for radiologists: As imaging physicians, we may not have access to the patient's full clinical history. The generated report will include a note that the referring clinician should assess for risk enhancers that may warrant upstaging.
Risk enhancers: Family hx premature ASCVD, primary hypercholesterolemia, metabolic syndrome, CKD, chronic inflammatory conditions, premature menopause, pregnancy-associated conditions, high-risk race/ethnicity, adverse lipids/biomarkers.
DECIDE Registry: Recommendations informed by the DECIDE registry framework — the largest prospective study investigating how HeartFlow's AI-enabled Plaque Analysis informs medical management. See Tzimas et al. and SCCT 2025 data.
✎
Generated Report Text
Fill in the fields above and click "Generate Report".
Reference 1 — Disease Severity Staging + Standard Medical Management
Reference 2 — QCPA Report Example (Plaque Assessment)
Reference 3 — QCPA Report Example (LDL Goals & Rx)
